HomeELAN • NYSE
add
Elanco Animal Health Inc
Previous close
$23.27
Day range
$22.58 - $23.52
Year range
$8.02 - $23.70
Market cap
11.24B USD
Avg Volume
5.37M
P/E ratio
161.50
Dividend yield
-
Primary exchange
NYSE
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.14B | 10.39% |
Operating expense | 580.00M | 6.81% |
Net income | -34.00M | -109.34% |
Net profit margin | -2.99 | -108.46% |
Earnings per share | 0.19 | 46.15% |
EBITDA | 195.00M | 25.81% |
Effective tax rate | 32.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 505.00M | 3.06% |
Total assets | 13.55B | 2.02% |
Total liabilities | 6.80B | 0.62% |
Total equity | 6.75B | — |
Shares outstanding | 496.86M | — |
Price to book | 1.71 | — |
Return on assets | 0.49% | — |
Return on capital | 0.62% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -34.00M | -109.34% |
Cash from operations | 219.00M | 35.19% |
Cash from investing | -101.00M | -108.12% |
Cash from financing | -153.00M | 88.58% |
Net change in cash | -34.00M | -145.95% |
Free cash flow | 217.38M | -76.57% |
About
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. Wikipedia
Founded
1954
Headquarters
Website
Employees
9,225
